![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELLULAR AND MOLECULAR
Department of Pharmacology, Teikyo University School of Medicine, Tokyo, Japan
Chronic complex I inhibition caused by rotenone induces features of Parkinson's disease in rats, including selective nigrostriatal dopaminergic degeneration and Lewy bodies with
-synuclein-positive inclusions. To determine the mechanisms underlying rotenone-induced neuronal death, we used an in vitro model of human dopaminergic SH-SY5Y cells. In rotenone-induced cell death, rotenone induced Bad dephosphorylation without changing the amount of Bad proteins. Rotenone also increased the amount of
-synuclein in cells showing morphological changes in response to rotenone. Because Bad and
-synuclein are known to bind to 14-3-3 proteins, we examined the effects of rotenone on these complexes. Whereas a decreased Bad amount bound to 14-3-3 proteins, rotenone increased
-synuclein binding to these proteins. Beccause dephosphorylation by calcineurin activates Bad, we examined the possible involvement of Bad activation in rotenone-induced apoptosis by using the calcineurin inhibitor tacrolimus (FK506). Tacrolimus suppressed two rotenone-induced actions: Bad dephosphorylation and apoptosis. Furthermore, the inhibition of caspase-9, which functions downstream from Bad, completely suppressed rotenone-induced apoptosis. Our findings demonstrate that Bad activation plays a role in rotenone-induced apoptosis of SH-SY5Y cells.
Address correspondence to: Dr. Toshio Nakaki, Department of Pharmacology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi Ward, Tokyo 173-8605, Japan. E-mail: nakaki{at}med.teikyo-u.ac.jp
This article has been cited by other articles:
![]() |
M. Watabe and T. Nakaki Mitochondrial Complex I Inhibitor Rotenone Inhibits and Redistributes Vesicular Monoamine Transporter 2 via Nitration in Human Dopaminergic SH-SY5Y Cells Mol. Pharmacol., October 1, 2008; 74(4): 933 - 940. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Watabe and T. Nakaki Mitochondrial Complex I Inhibitor Rotenone-Elicited Dopamine Redistribution from Vesicles to Cytosol in Human Dopaminergic SH-SY5Y Cells J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 499 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Watabe, K. Aoyama, and T. Nakaki Regulation of Glutathione Synthesis via Interaction between Glutamate Transport-Associated Protein 3-18 (GTRAP3-18) and Excitatory Amino Acid Carrier-1 (EAAC1) at Plasma Membrane Mol. Pharmacol., November 1, 2007; 72(5): 1103 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Samms, R. P. Perera, D. S. Wimalasena, and K. Wimalasena Perturbation of Dopamine Metabolism by 3-Amino-2-(4'-halophenyl)propenes Leads to Increased Oxidative Stress and Apoptotic SH-SY5Y Cell Death Mol. Pharmacol., September 1, 2007; 72(3): 744 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-L. Hsuan, H. M. Klintworth, and Z. Xia Basic fibroblast growth factor protects against rotenone-induced dopaminergic cell death through activation of extracellular signal-regulated kinases 1/2 and phosphatidylinositol-3 kinase pathways. J. Neurosci., April 26, 2006; 26(17): 4481 - 4491. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Potokar, M. Kreft, H. H. Chowdhury, N. Vardjan, and R. Zorec Subcellular localization of Apaf-1 in apoptotic rat pituitary cells Am J Physiol Cell Physiol, March 1, 2006; 290(3): C672 - C677. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Taille, J. El-Benna, S. Lanone, J. Boczkowski, and R. Motterlini Mitochondrial Respiratory Chain and NAD(P)H Oxidase Are Targets for the Antiproliferative Effect of Carbon Monoxide in Human Airway Smooth Muscle J. Biol. Chem., July 8, 2005; 280(27): 25350 - 25360. [Abstract] [Full Text] [PDF] |
||||